Ongentys

Active Ingredient(s): Opicapone
FDA Approved: * April 24, 2020
Pharm Company: * NEUROCRINE
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ongentys Overview

Opicapone, sold under the brand name Ongentys, is a medication which is administered together with levodopa in people with Parkinson's disease.[2] The most common side effects are dyskinesia (difficulty controlling movement), constipation, increased blood creatine kinase, hypotension/syncope, and decreased weight.[3][4] Opicapone, works to restore the levels of dopamine in the parts of the brain that control movement and coordination.[2&...

Read more Ongentys Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Opicapone

Recent Ongentys Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Opicapone
  • Capsule: 25mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ongentys: (2 results)

Sorted by National Drug Code
  • 70370-3025 Ongentys 25 mg Oral Capsule by Neurocrine Biosciences, Inc.
  • 70370-3050 Ongentys 50 mg Oral Capsule by Neurocrine Biosciences, Inc.

Other drugs which contain Opicapone or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 1 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA